Trials / Active Not Recruiting
Active Not RecruitingNCT04216576
A Study of the Use of Text Message Reminders to Take Palbociclib
Oral Self-Management of Palbociclib (Ibrance®) Using Mobile Technology
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Paper Drug Diary | Participants will receive and use a paper Drug Diary and a paper medication calendar. |
| OTHER | OhMD APP | Participants will receive multiple text messages regarding administration over time on medication self-management over the course of 3 cycles of medication |
Timeline
- Start date
- 2019-12-27
- Primary completion
- 2026-12-27
- Completion
- 2026-12-27
- First posted
- 2020-01-02
- Last updated
- 2026-03-27
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04216576. Inclusion in this directory is not an endorsement.